Skip to content

Bert Vogelstein

Howard Hughes Medical Institute

8 papers in the Anchorcite directory, published between 1988 and 2017, cited 56,394 times in total.

ORCID profile

Research topics

Frequent co-authors

Papers

  1. PD-1 Blockade in Tumors with Mismatch-Repair DeficiencyNew England Journal of Medicine · 2015 · 9,526 citations

    BACKGROUND: Somatic mutations have the potential to encode "non-self" immunogenic antigens. We hypothesized that tumors with a large number of somatic mutations due to mismatch-repair defects may be susceptible to immune checkpoint blockade. METHODS: We conducted a phase 2 study…

  2. WAF1, a potential mediator of p53 tumor suppressionCell · 1993 · 8,353 citations

    The ability of p53 to activate transcription from specific sequences suggests that genes induced by p53 may mediate its biological role as a tumor suppressor. Using a subtractive hybridization approach, we identified a gene, named WAF1, whose induction was associated…

  3. p53 Mutations in Human CancersScience · 1991 · 8,007 citations

    Mutations in the evolutionarily conserved codons of the p53 tumor suppressor gene are common in diverse types of human cancer. The p53 mutational spectrum differs among cancers of the colon, lung, esophagus, breast, liver, brain, reticuloendothelial tissues, and hemopoietic tissues.…

  4. Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine · 1988 · 6,809 citations

    Because most colorectal carcinomas appear to arise from adenomas, studies of different stages of colorectal neoplasia may shed light on the genetic alterations involved in tumor progression. We looked for four genetic alterations (ras-gene mutations and allelic deletions of chromosomes…

  5. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockadeScience · 2017 · 6,772 citations

    The genomes of cancers deficient in mismatch repair contain exceptionally high numbers of somatic mutations. In a proof-of-concept study, we previously showed that colorectal cancers with mismatch repair deficiency were sensitive to immune checkpoint blockade with antibodies to programmed death…

  6. IDH1 and IDH2 Mutations in GliomasNew England Journal of Medicine · 2009 · 5,993 citations

    BACKGROUND: A recent genomewide mutational analysis of glioblastomas (World Health Organization [WHO] grade IV glioma) revealed somatic mutations of the isocitrate dehydrogenase 1 gene (IDH1) in a fraction of such tumors, most frequently in tumors that were known to have…

  7. An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience · 2008 · 5,975 citations

    Glioblastoma multiforme (GBM) is the most common and lethal type of brain cancer. To identify the genetic alterations in GBMs, we sequenced 20,661 protein coding genes, determined the presence of amplifications and deletions using high-density oligonucleotide arrays, and performed gene…

  8. Lessons from Hereditary Colorectal CancerCell · 1996 · 4,959 citations

    A large body of evidence supports the idea that accumulated genetic changes underlie the development of neoplasia. This multistep process is well illustrated by colorectal cancers, which typically develop over decades and appear to require at least seven genetic events…

Metadata from OpenAlex (CC0).